A cohort study identified a link between COVID-19 and a faster decline in kidney function, especially following ...

Vedolizumab prevented the postoperative recurrence of Crohn’s disease and should be considered a prophylactic treatment in ...

An analysis of 6000 cardiac reoperations revealed timing between surgeries did not generally affect operative mortality, ...

Women with metabolic dysfunction-associated steatotic liver disease (MASLD) have a higher risk for cirrhosis, whereas men ...

Investigation on anti-diabetic efficacy of a Cucurbitaceae food plant from the North-East region of India: Exploring the molecular mechanism through modulation of oxidative stress and glycosylated ...

Studying the possible association between AI and cognitive dysfunction has accelerated over the past 7 years. A pilot study using neuropsychological testing from the Arimidex, Tamoxifen, Alone or ...

Why: Depression is common in late life, effecting nearly five million of the 31 million Americans aged 65 and older. Both major and minor depression are reported in 13% of community dwelling older ...

The study was conducted in two phases at four hospitals in the United Kingdom. In the first phase, data on consecutive UGI bleeders were collected at three hospitals prospectively and ...

The advocates of defined-contribution health plans extol the virtues of consumer-driven health care, consumer choice, and empowered consumers as solutions to the problems particularly the rapidly ...

Oxytetracycline 500 b.i.d. Inexpensive Take 30 min before food and not with milk Moderate Onycholysis Photosensitivity Benign intracranial hypertension Erythromycin 500 b.i.d. Inexpensive Take on ...

The use of combination or combined vaccines is an effective strategy to improve compliance and coverage in immunization schedules. However, it is reliant on the demonstration that coadministration ...

As their use increased, however, it became evident that anthracyclines carry a risk of cardiotoxicity, which in some cases could be irreversible, as well as a risk of secondary leukemia.